Ai Phage Therapy

Bacteriophage Biology

Doctoral work examines the viruses that infect and kill bacterial cells. Phage biology underpins every therapeutic application built upon these viruses.

Phage Diversity Research

Research examines the enormous variety of bacterial viruses across environments. Phages are the most abundant biological entities on the entire planet.

Phage Taxonomy Research

Doctoral study examines classifying bacterial viruses into meaningful groups. Classification has been substantially reorganised as genome data accumulated.

Phage Genomics Research

Research examines the genome sequences carried by bacterial viruses. Genome sequence determines both therapeutic suitability and potential safety concerns.

Phage Structure Research

Doctoral work examines the physical architecture of bacterial virus particles. Structural knowledge explains how these viruses recognise and enter cells.

Capsid Research

Research examines the protein shell enclosing the bacterial virus genome. Shell architecture determines particle stability during storage and delivery.

Tail Structure Research

Doctoral study examines the appendages many bacterial viruses use to attach. Tail machinery drives both host recognition and genome delivery into cells.

Receptor Binding Protein Research

Research examines the proteins recognising specific bacterial surface features. These proteins determine which bacterial strains a phage can infect.

Host Recognition Research

Doctoral work examines how bacterial viruses identify suitable target cells. Recognition specificity is the basis of the precision phage therapy offers.

Adsorption Research

Research examines bacterial viruses attaching to the surface of target cells. Attachment rate strongly influences how quickly infection can proceed.

Genome Injection Research

Doctoral study examines viral genetic material entering the bacterial cell. Injection machinery is remarkably sophisticated and incompletely understood.

Lytic Cycle Research

Research examines bacterial viruses replicating and then bursting their host. Strictly lytic behaviour is the requirement for therapeutic phage use.

Lysogenic Cycle Research

Doctoral work examines viruses integrating quietly into bacterial genomes. Integrating viruses are generally considered unsuitable for therapy.

Lysis Mechanism Research

Research examines how bacterial viruses break open their infected host cells. Lysis mechanisms are being developed as treatments in their own right.

Lysis Protein Research

Doctoral study examines the proteins coordinating destruction of the host cell. These proteins act with precise timing and remarkable efficiency.

Phage Replication Research

Research examines bacterial viruses copying their genomes within host cells. Replication efficiency determines how many particles each infection yields.

Phage Assembly Research

Doctoral work examines new virus particles assembling inside infected bacteria. Assembly is a highly ordered process involving many separate proteins.

Burst Size Research

Research examines how many new particles each infected bacterium releases. Burst size strongly influences whether an infection can spread through a population.

Latent Period Research

Doctoral study examines the interval between infection and host cell bursting. Timing determines how rapidly a phage population is able to expand.

Phage Gene Regulation

Research examines how bacterial viruses control the timing of gene activity. Regulatory switches determine whether a virus kills or integrates quietly.

Phage Protein Function Research

Doctoral work examines what individual bacterial virus proteins actually do. Most phage genes have no confidently assigned function whatsoever.

Auxiliary Gene Research

Research examines phage genes influencing host cell metabolism during infection. These genes reveal how viruses reshape the cells they have infected.

Phage Host Interaction

Doctoral study examines the molecular relationship between virus and bacterium. Interaction detail determines whether therapeutic infection will succeed.

Bacterial Defence System Research

Research examines the many systems bacteria use to resist viral infection. Bacteria carry a remarkable arsenal of antiviral defence mechanisms.

Restriction Modification Research

Doctoral work examines bacterial systems cutting recognised foreign genetic material. These systems were the first bacterial defences to be characterised.

CRISPR Defence Research

Research examines adaptive bacterial immunity targeting previously encountered viruses. This defence system became the foundation of genome editing tools.

Abortive Infection Research

Doctoral study examines infected bacteria dying to protect their neighbours. Self sacrifice limits viral spread through a bacterial population.

Phage Counterdefence Research

Research examines viral strategies overcoming bacterial defence systems. Counterdefence understanding guides selection of therapeutically robust phages.

Anti CRISPR Research

Doctoral work examines viral proteins disabling adaptive bacterial immunity. These proteins are useful both therapeutically and as laboratory tools.

Coevolution Research

Research examines viruses and bacteria evolving continuously against one another. This arms race has shaped microbial genomes across deep time.

Phage Resistance Research

Doctoral study examines bacteria becoming insensitive to therapeutic viruses. Resistance emerges rapidly and must be anticipated in treatment design.

Resistance Mechanism Research

Research examines the molecular routes by which bacteria escape infection. Mechanism knowledge guides construction of robust therapeutic mixtures.

Fitness Trade Off Research

Doctoral work examines costs bacteria incur when resisting viral infection. Resistant bacteria are frequently less virulent or less able to survive.

Surface Receptor Loss Research

Research examines bacteria losing the surface features viruses recognise. Losing these features frequently reduces bacterial ability to cause disease.

Phage Ecology Research

Doctoral study examines bacterial viruses within natural microbial communities. Ecological understanding informs both isolation and therapeutic expectation.

Environmental Phage Research

Research examines bacterial viruses present across natural environments. Environments are the source from which therapeutic phages are obtained.

Marine Phage Research

Doctoral work examines bacterial viruses within ocean and coastal waters. Marine viruses drive global nutrient cycling on an enormous scale.

Soil Phage Research

Research examines bacterial viruses inhabiting soil microbial communities. Soil is an extremely rich and underexplored source of novel phages.

Gut Phage Research

Doctoral study examines bacterial viruses within the human digestive tract. Gut viruses shape the bacterial communities living within the intestine.

Human Virome Research

Research examines the full viral population living within the human body. Most of these viruses infect bacteria rather than any human cells.

Population Dynamics Research

Doctoral work examines virus and bacterial numbers changing together over time. Dynamics determine whether therapeutic viruses can clear an infection.

Prophage Biology Research

Research examines viral sequence residing quietly within bacterial genomes. Resident viruses contribute substantially to bacterial gene content.

Temperate Phage Research

Doctoral study examines viruses capable of both killing and integrating. Temperate viruses are generally avoided for direct therapeutic use.

Prophage Induction Research

Research examines resident viruses reactivating and destroying their host. Induction can be triggered deliberately as a therapeutic strategy.

Transduction Research

Doctoral work examines viruses carrying bacterial genes between differing cells. Gene carriage is a safety concern for any therapeutic phage.

Horizontal Transfer By Phage

Research examines viruses spreading resistance and virulence genes between bacteria. This transfer is a principal route by which resistance spreads.

Phage Evolution Research

Doctoral study examines how bacterial viruses change across generations. Evolutionary capacity can be exploited to overcome bacterial resistance.

Genome Mosaicism Research

Research examines phage genomes assembled from many differing ancestral sources. Mosaic structure complicates both classification and safety assessment.

Phage Bioinformatics

Doctoral work examines computational analysis of bacterial virus sequence data. Computational tools built for bacteria handle phage genomes poorly.

Genome Annotation Research

Research examines assigning function to genes within phage genome sequences. Annotation is essential for judging whether a phage is safe to use.

Phage Isolation Research

Doctoral study examines obtaining new bacterial viruses from environmental sources. Isolation success determines what therapeutic options become available.

Environmental Sampling Research

Research examines where and how to sample for therapeutically useful viruses. Sewage and wastewater are the richest sources of clinically relevant phages.

Enrichment Method Research

Doctoral work examines laboratory methods increasing target virus abundance. Enrichment strategy determines which viruses are eventually recovered.

Host Range Research

Research examines which bacterial strains a given therapeutic virus can infect. Host range determines how many patients a single phage might treat.

Host Range Expansion Research

Doctoral study examines broadening the strains a therapeutic virus can attack. Broader range reduces the need for individual patient matching.

Broad Spectrum Phage Research

Research examines viruses naturally able to infect many bacterial strains. Broad range viruses suit ready prepared therapeutic phage products.

Phage Cocktail Design

Doctoral work examines combining several viruses into one therapeutic preparation. Mixtures cover more strains and delay emergence of resistance.

Cocktail Optimisation Research

Research examines choosing which viruses to combine and in what proportion. Composition determines both coverage and durability of the treatment.

Phage Synergy Research

Doctoral study examines viruses performing better together than individually. Synergy can arise where one virus exposes receptors for another.

Phage Bank Research

Research examines maintained collections of characterised therapeutic viruses. Banks permit rapid matching when a patient urgently requires treatment.

Collection Curation Research

Doctoral work examines maintaining and documenting therapeutic virus collections. Curation quality determines whether a collection is clinically usable.

Strain Matching Research

Research examines pairing a patient bacterial isolate with suitable viruses. Matching is the central practical step in personalised phage treatment.

Susceptibility Testing Research

Doctoral study examines laboratory testing of bacterial sensitivity to viruses. Testing methods lack the standardisation that antibiotic testing has.

Susceptibility Profiling Research

Research examines systematic profiling of which viruses kill a given isolate. Profiling is the phage equivalent of antibiotic sensitivity testing.

Rapid Matching Research

Doctoral work examines shortening the time required to match phage to patient. Speed matters greatly because these patients are frequently critically unwell.

Diagnostic Integration Research

Research examines connecting phage selection to routine microbiology services. Integration is essential for phage treatment to become widely practical.

Phage Screening Research

Doctoral study examines systematically testing viruses for therapeutic potential. Screening design determines which candidates progress toward clinical use.

High Throughput Screening

Research examines testing very many virus and bacteria combinations in parallel. Parallel testing accelerates matching and collection characterisation.

Characterisation Standard Research

Doctoral work examines what must be established before therapeutic virus use. Standards determine whether findings from differing groups are comparable.

Preparation Purity Research

Research examines removing bacterial material from therapeutic virus preparations. Residual bacterial material causes reactions when administered to patients.

Endotoxin Removal Research

Doctoral study examines removing inflammatory bacterial molecules from preparations. These molecules cause fever and shock if administered intravenously.

Contaminant Screening Research

Research examines detecting unwanted material within therapeutic preparations. Screening protects patients who are frequently already severely unwell.

Genome Safety Screening

Doctoral work examines checking phage genomes for concerning genetic content. Sequence screening is now expected before any therapeutic administration.

Virulence Gene Screening

Research examines detecting genes that could increase bacterial harmfulness. Viruses carrying such genes are excluded from therapeutic use entirely.

Resistance Gene Screening

Doctoral study examines detecting antimicrobial resistance genes within phage genomes. Carrying such genes would spread resistance rather than reduce it.

Lysogeny Screening Research

Research examines confirming that a therapeutic virus cannot integrate quietly. Integration capability generally excludes a virus from clinical use.

Phage Propagation Research

Doctoral work examines growing therapeutic viruses to the quantities required. Propagation must yield high numbers without introducing contamination.

Production Host Research

Research examines the bacterial strains used to grow therapeutic viruses. Host choice affects yield, purity and the safety of the final product.

Production Host Safety

Doctoral study examines ensuring production strains introduce no additional hazard. Production strains ideally carry no resistance or virulence genes.

Fermentation Research

Research examines controlled large scale growth of therapeutic virus preparations. Process control determines both consistency and achievable output.

Downstream Processing Research

Doctoral work examines recovering virus particles from production culture material. Downstream steps determine both final purity and product recovery.

Purification Method Research

Research examines separating therapeutic viruses from unwanted culture components. Purification must be gentle enough to preserve virus activity.

Concentration Method Research

Doctoral study examines raising virus numbers within a smaller final volume. Concentration is required because effective treatment demands high numbers.

Titre Determination Research

Research examines measuring how many active virus particles a preparation contains. Counting methods vary and complicate comparison between laboratories.

Potency Assay Research

Doctoral work examines measuring the killing capability of a virus preparation. Potency measurement is essential for consistent therapeutic dosing.

Preparation Stability Research

Research examines therapeutic viruses remaining active during their shelf life. Stability determines how products can be distributed and stored.

Storage Research

Doctoral study examines conditions preserving therapeutic virus activity over time. Storage requirements strongly constrain practical clinical availability.

Cold Chain Research

Research examines maintaining low temperature throughout distribution and storage. Cold requirements limit availability in many world regions.

Freeze Drying Research

Doctoral work examines drying preparations to permit storage without refrigeration. Dried products would transform accessibility in warmer regions.

Encapsulation Research

Research examines enclosing therapeutic viruses within protective carrier materials. Enclosure shields viruses from stomach acid and immune clearance.

Phage Formulation Research

Doctoral study examines preparing therapeutic viruses into administrable products. Formulation determines both stability and the routes available for use.

Excipient Research

Research examines inactive ingredients supporting therapeutic virus preparations. Excipient choice substantially affects virus survival during storage.

Manufacturing Scale Research

Doctoral work examines producing therapeutic viruses at clinically useful volumes. Scale is a substantial obstacle to routine therapeutic availability.

Good Practice Manufacture

Research examines meeting manufacturing standards for biological medicinal products. Standards were written for products far more uniform than phages.

Batch Consistency Research

Doctoral study examines achieving reproducible properties between production batches. Biological products vary in ways chemical products simply do not.

Quality Control Research

Research examines testing applied before therapeutic preparations are released. Testing must confirm identity, potency, purity and absence of contamination.

Release Testing Research

Doctoral work examines final checks before a preparation reaches a patient. Release testing must be rapid when patients are critically unwell.

Analytical Method Research

Research examines laboratory methods characterising therapeutic virus preparations. Method development lags substantially behind clinical demand.

Reference Material Research

Doctoral study examines standard preparations supporting measurement comparison. Shared references permit results to be compared between laboratories.

Standardisation Research

Research examines agreed methods and terminology across the phage therapy field. Lack of standardisation is a major barrier to accumulating evidence.

Phage Engineering Research

Doctoral work examines deliberately modifying bacterial viruses for therapeutic use. Engineering permits properties that natural isolation cannot provide.

Synthetic Phage Research

Research examines constructing bacterial viruses from synthesised genetic material. Construction permits designing viruses that do not exist naturally.

Genome Assembly Research

Doctoral study examines building complete phage genomes within the laboratory. Assembly methods determine how rapidly new designs can be tested.

Gene Removal Research

Research examines removing unwanted genes from therapeutic virus genomes. Removal eliminates integration capability and other safety concerns.

Host Range Engineering

Doctoral work examines modifying which bacterial strains a virus can infect. Engineered range reduces dependence on isolating new natural viruses.

Receptor Protein Engineering

Research examines redesigning the proteins determining bacterial target recognition. Redesign is the principal route to controlling host specificity.

Lysogeny Removal Research

Doctoral study examines converting integrating viruses into strictly killing ones. Conversion makes otherwise unsuitable viruses therapeutically usable.

Payload Delivery Research

Research examines viruses carrying additional functional genetic cargo. Cargo delivery extends what therapeutic viruses can achieve within bacteria.

Antimicrobial Gene Delivery

Doctoral work examines viruses delivering genes toxic to the targeted bacteria. Delivered genes can kill without requiring any virus replication.

Resistance Reversal Research

Research examines viruses delivering genes restoring antibiotic sensitivity. Restoring sensitivity could revive antibiotics that had stopped working.

Biofilm Targeting Engineering

Doctoral study examines engineering viruses to penetrate bacterial biofilm layers. Biofilms shelter bacteria from both antibiotics and immune attack.

Reporter Phage Research

Research examines viruses engineered to produce a detectable signal on infection. Signal producing viruses detect specific bacteria very rapidly.

Diagnostic Phage Research

Doctoral work examines using bacterial viruses to identify bacterial species. Virus based detection is specific, inexpensive and rapid to perform.

Phage Display Applications

Research examines presenting peptides or proteins on bacterial virus surfaces. Display underpins discovery of binding molecules across many fields.

Directed Evolution Research

Doctoral study examines evolving viruses in the laboratory toward desired properties. Evolution achieves improvements that rational design cannot.

Phage Training Research

Research examines repeatedly exposing viruses to resistant bacteria to improve them. Trained viruses regain effectiveness against resistant strains.

Machine Learning Applications

Doctoral work applies learned models across phage prediction and design tasks. Learned models require validation against genuine laboratory testing.

Host Range Prediction

Research examines predicting which bacteria a virus can infect from sequence. Prediction would greatly accelerate matching viruses to patients.

Genome Design Research

Doctoral study examines computationally designing therapeutic virus genomes. Design must respect the constraints natural virus genomes obey.

Protein Structure Prediction

Research examines predicting shapes of phage proteins from their sequences. Structural prediction accelerates engineering of recognition proteins.

Endolysin Therapeutic Research

Doctoral work examines phage enzymes used directly as antibacterial treatments. These enzymes kill bacteria without requiring any virus replication.

Engineered Lysin Research

Research examines modifying bacterial killing enzymes to improve their properties. Engineering extends activity toward bacteria with outer membranes.

Lysin Delivery Research

Doctoral study examines getting bacterial killing enzymes to their target site. Delivery is the principal obstacle for systemic enzyme treatment.

Depolymerase Research

Research examines phage enzymes degrading protective bacterial surface layers. These enzymes strip defences that shield bacteria from immune attack.

Phage Protein Therapeutic Research

Doctoral work examines individual phage proteins developed as medicines. Isolated proteins avoid the regulatory difficulties of whole viruses.

Phage Derived Nanostructure

Research examines using virus particles as engineered nanoscale materials. Virus particles are uniform, self assembling and readily modified.

Phage Vaccine Research

Doctoral study examines bacterial viruses used to present vaccine antigens. Virus particles are naturally highly visible to the immune system.

Phage Immunomodulation Research

Research examines bacterial viruses influencing human immune system responses. Phages interact with human immunity in ways only partly understood.

Combination With Antibiotics

Doctoral work examines therapeutic viruses used alongside antibiotic treatment. Combination is the commonest way phage treatment is actually given.

Antibiotic Synergy Research

Research examines viruses and antibiotics performing better in combination. Synergy has been demonstrated repeatedly in laboratory investigation.

Sequential Therapy Research

Doctoral study examines ordering virus and antibiotic treatment deliberately. Sequence affects whether resistance to either agent eventually emerges.

Combination With Other Agents

Research examines therapeutic viruses combined with other antibacterial approaches. Combination may achieve what no single approach manages alone.

Biofilm Disruption Research

Doctoral work examines therapeutic viruses penetrating established bacterial communities. Biofilm infections resist nearly all conventional treatment.

Persister Cell Research

Research examines dormant bacteria surviving treatment and later reviving. Dormant cells explain why many infections return after apparent cure.

Intracellular Bacteria Research

Doctoral study examines reaching bacteria hidden within human host cells. Hidden bacteria are inaccessible to most antibacterial treatments.

Polymicrobial Infection Research

Research examines infections involving several bacterial species together. Mixed infections complicate the precise targeting phages provide.

Resistance Prevention Strategy

Doctoral work examines designing treatment to limit emergence of resistance. Prevention strategy determines how durable phage treatment can be.

Phage Steering Research

Research examines using viruses to drive bacteria toward less harmful states. Steering exploits the costs bacteria pay when resisting infection.

Evolutionary Trap Research

Doctoral study examines forcing bacteria to choose between competing pressures. Trapping strategies make resistance to one agent costly elsewhere.

Nonlytic Approach Research

Research examines phage based approaches that do not burst bacterial cells. Avoiding bursting reduces release of inflammatory bacterial contents.

Preclinical Model Research

Doctoral work examines laboratory systems evaluating therapeutic virus candidates. Model choice determines whether findings transfer to human patients.

In Vitro Model Research

Research examines laboratory culture systems testing therapeutic virus activity. Culture testing predicts clinical performance only imperfectly.

Organoid Model Research

Doctoral study examines laboratory grown tissue models of human infection. Tissue models capture host responses that culture systems entirely lack.

Animal Model Research

Research examines animal studies of therapeutic virus safety and activity. Animal immune responses to viruses differ substantially from human ones.

Infection Model Research

Doctoral work examines experimental infections used to test treatment approaches. Model realism determines how far conclusions can be trusted.

Phage Pharmacokinetics

Research examines what the body does to administered therapeutic viruses. Viruses replicate within the body, unlike any conventional medicine.

Phage Distribution Research

Doctoral study examines where administered viruses travel within the body. Distribution determines whether viruses reach the infection site.

Phage Clearance Research

Research examines removal of administered viruses by the immune system. Rapid clearance limits how long treatment remains active in the body.

Phage Dosing Research

Doctoral work examines how much therapeutic virus should be administered. Dosing is unusual because viruses multiply once they reach their target.

Administration Route Research

Research examines how therapeutic viruses are delivered to the patient. Route selection depends entirely on where the infection is actually located.

Intravenous Administration Research

Doctoral study examines therapeutic viruses given directly into the bloodstream. Intravenous use demands the highest purity of any administration route.

Oral Administration Research

Research examines therapeutic viruses taken by mouth for intestinal infections. Stomach acid destroys most viruses without protective formulation.

Inhaled Administration Research

Doctoral work examines therapeutic viruses delivered directly into the lungs. Inhalation suits chronic respiratory infections particularly well.

Topical Administration Research

Research examines therapeutic viruses applied directly onto affected surfaces. Surface application achieves high local numbers with minimal exposure.

Local Instillation Research

Doctoral study examines placing therapeutic viruses directly at the infection site. Direct placement is common in bone, joint and device infections.

Immunogenicity Research

Research examines immune responses provoked by administered therapeutic viruses. Immune responses may limit repeated courses of the same virus.

Neutralising Response Research

Doctoral work examines antibodies inactivating administered therapeutic viruses. Neutralising antibodies develop and their clinical impact remains unclear.

Innate Immune Response Research

Research examines immediate immune reactions to administered virus preparations. Innate responses influence both clearance and treatment tolerability.

Phage Safety Research

Doctoral study examines the safety profile of therapeutic virus administration. Reported safety has been reassuring across accumulated clinical experience.

Adverse Event Research

Research examines harms occurring during therapeutic virus treatment. Systematic reporting has been inconsistent across published clinical cases.

Endotoxin Response Research

Doctoral work examines reactions caused by bacterial material within preparations. These reactions are preventable through adequate purification.

Compassionate Use Research

Research examines treatment provided outside formal trials for desperate cases. Most clinical phage experience has been gathered in this way.

Individual Patient Provision

Doctoral study examines preparations produced for one specific named patient. Individual production is central to how phage therapy currently operates.

Case Series Research

Research examines collected reports of individually treated patients. Case collections are informative and cannot establish treatment effectiveness.

Clinical Trial Design

Doctoral work examines designing controlled trials of therapeutic virus treatment. Trial design is difficult because each preparation may be individual.

Personalised Trial Design

Research examines trial designs accommodating individually matched treatments. Conventional trial designs fit personalised products very poorly.

Endpoint Selection Research

Doctoral study examines what phage therapy trials should actually measure. Endpoint choice determines whether genuine benefit is ever detected.

Control Condition Research

Research examines what therapeutic virus treatment should be compared against. Withholding treatment from desperately unwell patients raises ethical difficulty.

Trial Feasibility Research

Doctoral work examines whether proposed trials can practically be conducted. Recruitment is difficult because eligible patients are widely scattered.

Respiratory Infection Application

Research examines therapeutic viruses treating persistent lung infections. Lung infections are accessible by inhalation and frequently untreatable otherwise.

Cystic Fibrosis Application

Doctoral study examines phage treatment for infections in this inherited condition. Affected patients face lifelong infections resistant to antibiotics.

Bone And Joint Infection

Research examines therapeutic viruses treating deep skeletal infections. Bone infections are notoriously difficult to eradicate with antibiotics.

Prosthetic Infection Application

Doctoral work examines phage treatment of infected implanted medical devices. Device infections otherwise require removing the implant entirely.

Wound Infection Application

Research examines therapeutic viruses applied directly to infected wounds. Wounds are accessible and suit direct surface application very well.

Burn Infection Application

Doctoral study examines phage treatment of infections complicating burn injury. Burn infections are severe and frequently resistant to antibiotics.

Urinary Infection Application

Research examines therapeutic viruses treating persistent urinary infections. The urinary tract is accessible by direct instillation of preparations.

Bloodstream Infection Application

Doctoral work examines phage treatment of severe bloodstream infections. These infections are life threatening and demand immediate effective treatment.

Gastrointestinal Application

Research examines therapeutic viruses treating infections of the digestive tract. Oral administration reaches the gut with appropriate protection.

Skin Infection Application

Doctoral study examines phage treatment applied to infected skin conditions. Surface application avoids the difficulties of systemic administration.

Decolonisation Research

Research examines removing resistant bacteria carried without active infection. Removing carriage could prevent later infection and onward spread.

Regulatory Framework Research

Doctoral work examines rules governing therapeutic virus products and their use. Existing frameworks fit these products extremely awkwardly.

Personalised Product Regulation

Research examines regulating products prepared for one individual patient. Regulation assumes uniform products manufactured in identical batches.

Pharmacy Preparation Research

Doctoral study examines preparations made within pharmacies for named patients. This route has permitted treatment where no approved product exists.

Approval Pathway Research

Research examines routes toward formal authorisation of phage based products. No conventional pathway suits products that must be individually matched.

Phage Therapy Ethics

Doctoral work examines ethical questions raised by therapeutic virus treatment. Desperate patients cannot give entirely unpressured consent.

Consent Research

Research examines consent for treatment with an unproven therapeutic approach. Consent must convey genuine uncertainty about likely individual benefit.

Access And Equity Research

Doctoral study examines who obtains phage treatment and who does not. Access currently depends heavily upon geography and personal advocacy.

Health Economics Research

Research evaluates the value delivered by therapeutic virus treatment. Individual preparation makes conventional economic evaluation difficult.

Global Access Research

Doctoral work examines phage therapy availability across differing world regions. Resistance burden falls heaviest where treatment access is weakest.

Low Resource Setting Research

Research examines phage treatment where laboratory infrastructure is limited. Local isolation may suit settings that cannot import biological products.

Clinical Service Research

Doctoral study examines organising services that deliver phage treatment. Service models must connect laboratories, pharmacies and clinicians.

Multidisciplinary Practice

Research examines the differing professions required to deliver this treatment. Delivery demands microbiology, pharmacy and clinical expertise together.

Practitioner Training Research

Doctoral work examines preparing clinicians and scientists to use these treatments. Expertise is extremely scarce and concentrated in few centres.

Public Understanding Research

Research examines public perception of treatment using bacterial viruses. Public understanding shapes both acceptance and regulatory pressure.

Veterinary Phage Research

Doctoral study examines therapeutic viruses treating infections in animals. Veterinary use faces fewer regulatory barriers than human treatment.

Agricultural Phage Research

Research examines bacterial viruses controlling plant and livestock disease. Agricultural use reduces reliance on antimicrobials in food production.

Food Safety Application

Doctoral work examines bacterial viruses reducing pathogens within food products. Several such products have already received regulatory approval.

Environmental Application

Research examines bacterial viruses applied within environmental settings. Environmental use includes wastewater and surface decontamination.

Biocontrol Application Research

Doctoral study examines viruses controlling harmful bacteria outside medicine. Biocontrol applications face far lighter regulatory requirements.

Implementation And Adoption

Research examines why phage therapy is or is not adopted into practice. Adoption depends on regulation and infrastructure as much as evidence.